FIELD: biotechnology.
SUBSTANCE: invention discloses the use of type III polyketide synthases in in vitro or in vivo systems for producing hispidin, a method for producing hispidin in in vitro or in vivo systems using said type III polyketide synthase and a kit for producing hispidin in expression systems in vitro and in vivo, comprising said type III polyketide synthase.
EFFECT: invention provides an efficient method for synthesis of hispidin.
9 cl, 9 dwg, 6 tbl, 25 ex
| Title | Year | Author | Number |
|---|---|---|---|
| LUCIFERIN BIOSYNTHESIS ENZYMES AND USE THEREOF | 2018 |
|
RU2730038C2 |
| CAFFEYLPYRUVATE HYDROLASES AND THEIR USE | 2020 |
|
RU2812474C2 |
| HISPIDIN SYNTHASES AND THEIR USE | 2020 |
|
RU2809367C2 |
| IMMUNOCYTOKINES BASED ON IL-15 AND IL-15Rα OF THE SUSHI DOMAIN | 2012 |
|
RU2763298C2 |
| MULTIMERIZING POLYPEPTIDES DERIVED FROM DOMAIN WITH ROLL-TYPE PENTONE BASE OF ADENOVIRUS | 2019 |
|
RU2820522C2 |
| HPV-SPECIFIC BINDING MOLECULES | 2018 |
|
RU2804664C2 |
| DOG ANTIBODIES WITH MODIFIED CH-CH SEQUENCES | 2014 |
|
RU2815059C2 |
| CD123-SPECIFIC CHIMERIC ANTIGENIC RECEPTORS FOR CANCER IMMUNOTHERAPY | 2015 |
|
RU2727290C2 |
| METHODS AND PRODUCTS FOR PRODUCING AND DELIVERING NUCLEIC ACIDS | 2015 |
|
RU2714404C2 |
| DOG ANTIBODIES WITH MODIFIED CH2-CH3 SEQUENCES | 2014 |
|
RU2801209C2 |
